The position, new to the Tulane SPHTM, will be partially funded by the university’s Center for Infectious Diseases and has been launched with the goal of further increasing research within the school as well as university-wide collaborative research activities.
Dr. Bansal comes to Tulane from the National Institutes of Health where she served as a program officer in the Division of AIDS, NIAID. Previously, she held the positions of scientific review administrator (NIAID), primary patent examiner (US Patent and Trademark Office), and director of the Department of Antibody and Vaccine Discovery at MedImmune, Inc.
Prior to rising to the director level, Dr. Bansal spent several years as a research scientist for MedImmune. “Thus, her experience as both a researcher and an administrator will prove invaluable to Tulane,” said Dean Buekens.
Dr. Bansal received her M.Sc. in biophysics from the All India Institute in New Delhi, India, and her Ph.D. in biochemistry and immunology from the University of Maryland.